A unique cross-linked hyaluronic acid canalicular gel designed for lacrimal occlusion, which is preservative-free¹

Each administration provides dry eye relief for 6 months²

Designed to adapt to each unique lacrimal system, resulting in ease of administration and patient comfort¹

Intended for use in adult patients experiencing dry eye symptoms²

While Lacrifill^® is generally well-tolerated, the most prevalent adverse event reported is epiphora (overflow of tears)¹; for full instructions for use, contraindications, and a complete list of potential adverse events, please see the IFU

Lacrifill^® is a FDA-cleared and CE-marked medical device

Lacrifill^® comes in a pre-filled syringe with 0.6ml of gel, containing enough gel to fully fill both inferior canaliculi of a single patient²

Lacrifill^® can be administered by healthcare professionals such as ophthalmologists and optometrists in a standard practice setting¹

Lacrifill^®’s administration relies on 3 key steps